Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Farley

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|February 19, 2011
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group studyJohn Farley, Michael W Sill, Michael Birrer, et al.
Gynecologic Oncology|July 30, 2020
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group studyKrishnansu S Tewari, Michael W Sill, Robert L Coleman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomasCharlie Gourley, John Farley, Diane M Provencher, et al.
Cancer Epidemiology|July 22, 2021
Cancer mortality in a population-based cohort of American Indians - The strong heart studyDorothy A Rhoades, John Farley, Stephen M Schwartz, et al.
Pediatrics|August 31, 2018
Pediatric Antibacterial and Antifungal Trials From 2007 to 2017Joshua T Thaden, Karen Chiswell, Ian Jaffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trialDaniela Matei, Michael W Sill, Heather A Lankes, et al.
The Lancet. Oncology|December 25, 2012
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 studyJohn Farley, William E Brady, Vinod Vathipadiekal, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation InitiativeRachel G Greenberg, Amy Corneli, John Bradley, et al.
Gynecologic Oncology Reports|July 21, 2025
Identifying and breaking barriers: Addressing disparities in the care of patients with gynecologic cancersBhavana Pothuri, Michele Muir, Jean Hurteau, et al.
Plos One|November 20, 2025
A qualitative study exploring motivations for participating in research among women who use opioidsSarah M Bagley, Ariel D Maschke, Miriam T H Harris, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|February 19, 2011
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group studyJohn Farley, Michael W Sill, Michael Birrer, et al.
Gynecologic Oncology|July 30, 2020
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group studyKrishnansu S Tewari, Michael W Sill, Robert L Coleman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomasCharlie Gourley, John Farley, Diane M Provencher, et al.
Cancer Epidemiology|July 22, 2021
Cancer mortality in a population-based cohort of American Indians - The strong heart studyDorothy A Rhoades, John Farley, Stephen M Schwartz, et al.
Pediatrics|August 31, 2018
Pediatric Antibacterial and Antifungal Trials From 2007 to 2017Joshua T Thaden, Karen Chiswell, Ian Jaffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trialDaniela Matei, Michael W Sill, Heather A Lankes, et al.
The Lancet. Oncology|December 25, 2012
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 studyJohn Farley, William E Brady, Vinod Vathipadiekal, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation InitiativeRachel G Greenberg, Amy Corneli, John Bradley, et al.
Gynecologic Oncology Reports|July 21, 2025
Identifying and breaking barriers: Addressing disparities in the care of patients with gynecologic cancersBhavana Pothuri, Michele Muir, Jean Hurteau, et al.
Plos One|November 20, 2025
A qualitative study exploring motivations for participating in research among women who use opioidsSarah M Bagley, Ariel D Maschke, Miriam T H Harris, et al.
Pageof 7